Orbán-Kálmándi Rita Angéla

Contact

Name: Orbán-Kálmándi Rita Angéla

Profession

Media links

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2018-2024

2024

Tóth, E., Orbán-Kálmándi, R., Bagoly, Z., Lóczi, L., Deli, T., Török, O., Deliné Molnár, S., Baráth, S., Singh, P., Hevessy, Z., Katona, É., Fagyas, M., Szabó, A., Molnár, S., Krasznai, Z.: Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Front. Immunol. 15 1-10, 2024.

Journal metrics:

Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
Mátrai, Á., Varga, Á., Baráth, B., Ványolos, E., Orbán-Kálmándi, R., Lóczi, L., Bagoly, Z., Jouppila, A., Lassila, R., Németh, N., Deák, Á.: Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model.
J Thromb Thrombolysis. [Epub ahead of print]2024.

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine (2023)
Q2 Hematology (2023)
Lóczi, L., P. Szabó, R., Orbán-Kálmándi, R., Hodossy-Takács, R., Szilvási, A., Szalai, Z., Nagy, G., Antal-Szalmás, P., Nemes, B., Bagoly, Z.: Increased thrombin generation in kidney transplant recipients with donor-specific antibodies directed against human leukocyte antigens.
Front. Immunol. "Accepted by Publisher"2024.

Journal metrics:

Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
Ghansah, H., Orbán-Kálmándi, R., Bekéné Debreceni, I., Katona, É., Rejtő, L., Váróczy, L., Lóczi, L., Laat, B., Huskens, D., Kappelmayer, J., Bagoly, Z.: Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Thromb. Res. 234 12-20, 2024.

Journal metrics:

Q1 Hematology (2023)

2023

Árokszállási, T., Balogh, E., Orbán-Kálmándi, R., Pásztor, M., Árokszállási, A., Nagy, E., Belán, I., May, Z., Csépány, T., Csiba, L., Bagoly, Z., Oláh, L.: Elevated Blood Alcohol Concentration Is Associated with Improved Clinical Outcomes of Intravenous Thrombolysis Treatment in Acute Ischemic Stroke Patients: A Retrospective Study.
J Clin Med. 12 (6), 1-13, 2023.

Journal metrics:

Q1 Medicine (miscellaneous)

2022

Sadeghi, F., Sarkady, F., Zsóri, K., Szegedi, I., Orbán-Kálmándi, R., Székely, E., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z., Shemirani, A.: High Neutrophil-Lymphocyte Ratio and Low Lymphocyte-Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke.
J. Pers. Med. 12 (8), 1-12, 2022.

Journal metrics:

Q2 Medicine (miscellaneous)
Székely, E., Orbán-Kálmándi, R., Szegedi, I., Katona, É., Baráth, B., Czuriga-Kovács, K., Lóczi, L., Molnárné Vasas, N., Fekete, I., Fekete, K., Berényi, E., Oláh, L., Csiba, L., Bagoly, Z.: Low [alfa]2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
Front. Cardiovasc. Med. 9 1-14, 2022.

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine
Lóczi, L., Orbán-Kálmándi, R., Árokszállási, T., Fekete, I., Fekete, K., Héja, M., Tóth, J., Csiba, L., Bagoly, Z.: Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage.
Front. Neurol. 13 1-12, 2022.

Journal metrics:

Q2 Neurology
Q2 Neurology (clinical)

2021

Orbán-Kálmándi, R., Szegedi, I., Sarkady, F., Fekete, I., Fekete, K., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z.: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis.
Sci. Rep. 11 (1), 1-14, 2021.

Journal metrics:

D1 Multidisciplinary
Orbán-Kálmándi, R., Árokszállási, T., Fekete, I., Fekete, K., Héja, M., Tóth, J., Sarkady, F., Csiba, L., Bagoly, Z.: A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients: the IRONHEART Study.
Front. Neurol. 12 1-11, 2021.

Journal metrics:

Q2 Neurology
Q1 Neurology (clinical)
Szegedi, I., Orbán-Kálmándi, R., Nagy, A., Sarkady, F., Molnárné Vasas, N., Sik, M., Lánczi, L., Berényi, E., Oláh, L., Crișan, A., Csiba, L., Bagoly, Z.: Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
PLoS One. 16 (7), 1-16, 2021.

Journal metrics:

Q1 Multidisciplinary
Bagoly, Z., Baráth, B., Orbán-Kálmándi, R., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, 2021.

Journal metrics:

Q2 Biochemistry
Q2 Molecular Biology
Árokszállási, T., Héja, M., Bagoly, Z., Kovács, K., Orbán-Kálmándi, R., Sarkady, F., Tóth, J., Fekete, K., Fekete, I., Csiba, L.: Prognostic value of various hemostasis parameters and neurophysiological examinations in spontaneous intracerebral hemorrhage: the IRONHEART study protocol.
Front. Neurol. 12 1-6, 2021.

Journal metrics:

Q2 Neurology
Q1 Neurology (clinical)

2020

2019

Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Tóth, N., Csiba, L.: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: a Review of the Literature.
Front. Neurol. 10 1-13, 2019.

Journal metrics:

Q2 Neurology
Q2 Neurology (clinical)
Orbán-Kálmándi, R., Szegedi, I., Fekete, I., Fekete, K., Sarkady, F., Varga, L., Csiba, L., Bagoly, Z.: The use of ex vivo clot lysis assay for predicting outcomes in acute ischemic stroke patients who underwent intravenous thrombolysis.
Eur. Stroke J. 4 (Suppl.), 742-743, 2019.

2018

Baráth, B., Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: Incorporation of Alpha-2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy.
Proceedings. 2 (9), 101-102, 2018.
Bagoly, Z., Baráth, B., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: The Effect of Factor XIII Levels on the Incorporation of [alfa]2-plasmin Inhibitor into Fibrin Clots: association with the Therapeutic Outcome of Acute Ischemic Stroke Patients.
Res. Pract. Thromb. Haemost. 2 198-198, 2018.

updated: 2024-12-01, 02:18

You are here

Orbán-Kálmándi Rita Angéla

Orbán-Kálmándi Rita Angéla

Publication list

SCImago quartiles of
scientific journal articles

SCImago subject areas and categories

Genre chart

Year chart

Language chart

Journals

iDEa co-authors

Other co-authors

You are here

Orbán-Kálmándi Rita Angéla

Orbán-Kálmándi Rita Angéla

Publication list

SCImago quartiles ofscientific journal articles

SCImago subject areas and categories

Genre chart

Year chart

Language chart

Journals

iDEa co-authors

Other co-authors

SCImago quartiles of
scientific journal articles